Access Bio Balance Sheet Health
Financial Health criteria checks 5/6
Access Bio has a total shareholder equity of ₩587.1B and total debt of ₩23.8B, which brings its debt-to-equity ratio to 4%. Its total assets and total liabilities are ₩691.1B and ₩104.0B respectively. Access Bio's EBIT is ₩21.9B making its interest coverage ratio -2. It has cash and short-term investments of ₩347.0B.
Key information
4.0%
Debt to equity ratio
₩23.77b
Debt
Interest coverage ratio | -2x |
Cash | ₩346.98b |
Equity | ₩587.14b |
Total liabilities | ₩104.00b |
Total assets | ₩691.14b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A950130's short term assets (₩418.4B) exceed its short term liabilities (₩44.0B).
Long Term Liabilities: A950130's short term assets (₩418.4B) exceed its long term liabilities (₩60.0B).
Debt to Equity History and Analysis
Debt Level: A950130 has more cash than its total debt.
Reducing Debt: A950130's debt to equity ratio has reduced from 99.9% to 4% over the past 5 years.
Debt Coverage: A950130's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A950130 earns more interest than it pays, so coverage of interest payments is not a concern.